ロード中...
Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy
Monoclonal antibodies are widely used to treat non-infectious conditions but are costly. Vaccines could offer a cost-effective alternative but have been limited by sub-optimal T-cell stimulation and/or weak vaccine responses in recipients, for example, in elderly patients. We have previously shown t...
保存先:
| 出版年: | NPJ Vaccines |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5653761/ https://ncbi.nlm.nih.gov/pubmed/29263885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-017-0030-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|